Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Notified Bodies Group: New Euro AI Regs Could Cause Undue Burdens

Executive Summary

The European medical devices notified bodies association says a proposed rule published earlier in the year risks forcing manufacturers, regulators and notified bodies to duplicate their work.

You may also be interested in...



Digital Health Roundup: Digital Therapeutics Push Ahead On Standards, Coverage; FDA’s Software Guidance

In this roundup feature focusing on developments in digital health, we highlight the key news and announcements from October.

US, UK, Canada Agree On Good Machine Learning Practices

The principals recommended by the three countries could be the foundation for how their regulatory bodies intend to regulate future AI/ML products.

US FDA Proposes Independent Contractor To Track User Fee Dollars Used To Pay FTEs

The agency published minutes from three MDUFA V user fee meetings with medtech industry. The talks include conversations about carryover funds and filling FTEs from past user fee deals.

Topics

UsernamePublicRestriction

Register

MT144625

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel